Hormones in saliva

Critical Reviews in Clinical Laboratory Sciences

Volumn 23, Issue 2, 1986, Pages 95-146

  Vining, Ross F ^a   Mcginley, Robynne A ^a,b  

^a ST VINCENT S HOSPITAL   (Australia)

^b Tenovus Institute   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; CARCINOEMBRYONIC ANTIGEN; CORTICOSTEROID; ESTROGEN; GESTAGEN; GONADOTROPIN; GROWTH PROMOTOR; HORMONE; MINERALOCORTICOID; PANCREAS HORMONE; PLASMA PROTEIN; THYROID HORMONE;

AGE; CIRCADIAN RHYTHM; ELECTROLYTE BALANCE; FEMALE; HUMAN; LABORATORY DIAGNOSIS; MALE; METABOLISM; METHODOLOGY; PH; PROTEIN BINDING; REVIEW; SALIVA; TRANSPORT AT THE CELLULAR LEVEL;

ADRENAL CORTEX HORMONES; AGE FACTORS; ANDROGENS; BIOLOGICAL TRANSPORT; BLOOD PROTEINS; CARCINOEMBRYONIC ANTIGEN; CIRCADIAN RHYTHM; ESTROGENS; FEMALE; GONADOTROPINS; GROWTH SUBSTANCES; HORMONES; HUMAN; HYDROGEN-ION CONCENTRATION; MALE; MINERALOCORTICOIDS; PANCREATIC HORMONES; PROGESTATIONAL HORMONES; PROTEIN BINDING; SALIVA; SPECIMEN HANDLING; THYROID HORMONES; WATER-ELECTROLYTE BALANCE;

EID: 0022575221     PISSN: 10408363     EISSN: None     Source Type: Journal    
DOI: 10.3109/10408368609165797     Document Type: Article

References (242)

1. Transport in salivary and salt glands
2. Passage of immunoglobulins from plasma to the oral cavity in rhesus monkeys
3. Secretory processes in salivary glands
4. Composition of saliva in mammalia
5. Preliminary observation on the presence and origins of serum albumin on human saliva
6. Structure and biological functions of human IgD. XIV. The development of a solid-phase radioimmunoassay for the quantitation of IgD in human sera and secretions
7. Concentration of immunoglobulins in human whole saliva: effect of physiological stimulation
8. Lactoferrin concentration in the parotid saliva of patients with chronic pancreatitis
9. Detection of pregnancy associated alpha 2-glycoprotein (alpha 2-PAG), an immunosuppressive agent, in IgA producing plasma cells and in body secretions
10. Hepatitis B antigen in saliva, urine, and stool
11. Hepatitis B surface antigen in saliva of HB-SAg carriers
12. Salivary enzymes—origin and relationship to peridontal disease
13. Salivary total oestriol through normal pregnancy and some clinical aspects of oestriol determinations
14. Salivary steroid measurement: an alternative approach to plasma assays in assessing endocrine function
15. Hormones in saliva: mode of entry and consequent implications for clinical interpretation
16. Radioimmunoassay of 17 alpha-hydroxyprogesterone in saliva, parotid fluid, and plasma of congenital adrenal hyperplasia patients
17. The assay of salivary cortisol
18. The secretion of non-electrolytes in the parotid saliva
19. Changes in the permeability of the salivary gland caused by sympathetic stimulation and by catecholamines
20. Epidermal growth factor (urogastrone) in human fluids: size heterogeneity
21. Transport of steroids from blood to saliva
22. Determination of androstenedione in saliva
23. The biologic significance of the aldosterone concentration in saliva
24. Salivary cortisol. I. Monitoring changes in normal adrenal activity
25. Discussion
26. Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid binding globulin in human plasma
27. chap. 4
28. Transport of protein-bound hormones into tissues in vivo
29. Free cortisol in human plasma
30. Evaluation of methods to determine protein-binding of drugs. Equilibrium dialysis, ultrafiltration, ultracentrifugation and gel filtration
31. Radioimmunological determination of apparent free cortisol concentration. Some physiological and clinical applications
32. Estimation of the percentage of free steroids in undiluted serum by centrifugal ultrafiltration-dialysis
33. Accurate measurement of steroid-protein binding by steady state gel filtration
34. Errors in interpretation of data from equilibrium dialysis protein binding experiments
35. The 17-hydroxycorticosteroids of parotid fluid, serum and urine following intramuscular administration of repository corticotropin
36. Identification and significance of parotid fluid corticosteroids
37. Parotid fluid steroid responses to ACTH in surgically confirmed cases of Cushing's syndrome
38. Dexamethasone suppression tests employing parotid fluid
39. Effect of exercise on parotid fluid corticosteroids and electrolytes
40. Adrenal corticosteroids in submaxillary fluid
41. Parotid fluid cortisol and cortisone
42. Seasonal changes in circadian rhythms of human salivary corticosteroids and electrolytes (computer analysis using the “Cosinor” program)
43. Variations in the salivary concentrations of cortisol and cortisone in normal women and during pregnancy
44. Parotid steroid excretion in relation to plasma cortisol variations
45. Adrenal status assessed by direct radioimmunoassay of cortisol in whole saliva or parotid saliva
46. Steroids in saliva for assessing endocrine function
47. Salivary cortisol determination: adaption of a commercial serum cortisol kit
48. Radioimmunoassay of cortisol in saliva with the “Gamma Coat” kit (letter)
49. Polarisation fluoroimmunoassay of serum and salivary cortisol
50. Corticosteroid analysis in biological fluids by high-performance liquid chromatography
51. Salivary cortisol: a better measure of adrenal cortical function than serum cortisol
52. Salivary cortisol assays for assessing pituitary-adrenal reserve
53. Use of saliva for monitoring unbound free cortisol levels in serum
54. Cortisol and cortisone in saliva
55. Increased content of saliva cortisol following infusion of ioglycamate
56. Direct assay of cortisol in human saliva by solid phase radioimmunoassay and its clinical applications
57. Physiological and pathological variations in saliva cortisol
58. Age of appearance of circadian rhythm in salivary cortisol values in infancy
59. Saliva cortisol levels following dexamethasone administration in endogenously depressed patients
60. Responses of salivary cortisol levels to stress-situations
61. Effect of intermittent (traffic) noise on man—temporary threshold shift, and change in urinary 17-OHCS and saliva cortisol levels
62. Effects of cigarettes on saliva cortisol levels
63. Salivary cortisol and DHEAS levels in postmenopausal women with primary breast cancer
64. Salivary cortisol determinations in the assessment of adrenal activity
65. Utilization of 11-beta-hydroxysteroids by the salivary gland ducts
66. Kinetic study of 11-beta-hydroxysteroid dehydrogenase in rat submandibular salivary gland
67. Prednisolone concentrations in plasma, saliva and urine
68. Salivary kinetics of prednisolone in man
69. The development of a radioimmunoassay for measurement of prednisolone (total and free) in serum and saliva from asthmatic children
70. Polarization fluoroimmunoassay of 11-deoxycortisol in serum and saliva
71. Determination of the mineralocorticoid activity of the adrenal glands by means of saliva tests
72. Binding of aldosterone to plasma proteins
73. Differences in antipodal specificity in the binding of steroids to serum proteins
74. Corticosteroid binding plasma protein
75. Aldosterone-protein interaction
76. Increased plasma protein binding and lower metabolic clearance rate of aldosterone in plasma of low cortisol concentration
77. A simple solid phase enzyme immunoassay for aldosterone in plasma and saliva
78. Analysis of testosterone and dehydroepiandrosterone in saliva by gas chromatography-mass spectrometry
79. Testosterone in human saliva
80. Radioimmunoassay for “free” testosterone in human saliva
81. Salivary testosterone: relationship to unbound plasma testosterone in normal and hyperandrogenic women
82. Changes in male salivary testosterone concentration with age
83. Assessment of testicular function by the radioimmunoassay of testosterone in saliva
84. Salivary testosterone in men: further evidence of a direct correlation with the free serum testosterone
85. Abnormal salivary steroid levels in prostate cancer
86. Saliva as a matrix for measuring free androgens: comparison with serum androgens in polycystic ovarian disease
87. Saliva and serum testosterone following oral testosterone undecanoate administration in normal and hypogonadal men
88. Salivary and serum testosterone under physiological and pharmacological conditions
89. Salivary hormone levels in infants and children
90. Testosterone concentrations in human seminal plasma and saliva and its correlation with non-protein bound and total testosterone levels in serum
91. Applicability of salivary testosterone measurements for the follow-up therapy of idiopathic hirsutism
92. Specificity of androgen measurements in saliva
93. Salivary and plasma bound and free testosterone in men and women
94. A sensitive enzymeimmunoassay with a fluorimetric end-point for the determination of testosterone in female plasma and saliva
95. Circadian rhythms of testosterone and cortisol in saliva: effects of activity-phase shifts and continuous daylight
96. Testosterone in saliva of normal men and its relationship with unbound and total testosterone levels in plasma
97. Androgens in saliva
98. Testosterone secretion and metabolism in male senescence
99. Reproductive hormones in aging men. I. Measurement of sex steroids, basal LH and Leydig cell response to hCG
100. The influence of age, alcohol consumption and body build on gonadal function in men
101. Variation of salivary testosterone with age in men
102. Salivary testosterone in the male adolescent
103. Testosterone and delta 4-androstenedione in the saliva of patients with Klinefelter's syndrome
104. Sex hormonebinding globulin and saliva testosterone levels in men with androgenic alopecia
105. Ketoconazole-induced drop in serum and saliva testosterone
106. The pituitary-testicular axis in prostatic disease: the potential of salivary steroid assays
107. Plasma and salivary androstenedione and dihydro-testosterone in women with hyperandrogenism
108. The occurrence of testosterone and 5-alpha-dihydrotestosterone in the submaxillary salivary gland of the boar
109. Radioimmunoassay of testosterone, 5-alpha-dihydrotestosterone and estrone in saliva for the evaluation of idiopathic hirsutism
110. Evaluation of hirsutism by radioimmunoassay of testosterone, dihydrotestosterone and estrone in saliva
111. A selective radioimmunoassay of androstenedione in plasma and saliva
112. Salivary and plasma androstenedione and 17-hydroxyprogesterone levels in congenital adrenal hyperplasia
113. Identification and quantification of dehydroepian-drosterone sulphate in saliva
114. Determination of salivary DHEAS: application to breast cancer research
115. Salivary cortisol and dehydroepiandrosterone sulphate levels in postmenopausal women with primary breast cancer
116. Estimation of the odorous steroid, 5 alpha-androst-16-en-3-one, in human saliva
117. Salivary cues in the mouse: a preliminary study
118. Antenatal sex determination. A historical review
119. Saliva test for prenatal sex determination
120. Evaluation of the saliva prenatal sex test
121. Sex prediction through the use of maternal saliva
122. Prenatal sex determination from the maternal saliva (author's translation)
123. Maternal serum total and free testosterone and saliva testosterone at term pregnancy: prediction of fetal sex
124. Radioimmunoassay of estrone in male saliva
125. Metabolism of estrone and progesterone in vitro in human saliva
126. Plasma and salivary ovarian steroids in fertile and infertile women during the menstrual cycle
127. Analyses of steroids in saliva using highly selective mass spectrometric techniques
128. Salivary and plasma progesterone and oestradiol during the menstrual cycle and pregnancy
129. Oestradiol in saliva during the menstrual cycle
130. Assays of oestradiol and progesterone in saliva in the assessment of ovarian function
131. Progesterone and estradiol in the saliva and plasma during the menstrual cycle
132. Oestrogens in saliva
133. Saliva oestradiol response to DHEA and DHEAS administration in placental sulphatase deficiency
134. Hormone basis of risk factors for breast and endometrial cancer
135. The basis and application of estrogen assays on urine and blood to assess fetoplacental function in late pregnancy
136. Biochemical parameters for surveillance of high-risk pregnancies
137. Oestrogens in saliva
138. Secretion of oestrogens into the saliva during pregnancy in the human
139. Relation of estriol in saliva to serum during normal pregnancy
140. Salivary estriol in normal pregnancy
141. Radioimmunoassay for salivary estriol, with use of a solid-phase separation technique
142. Saliva estriol measurements: an alternative to the assay of serum unconjugated estriol in assessing fetoplacental function
143. Salivary unconjugated estriol levels in normal third trimester pregnancy—direct correlation with serum levels
144. Influence of sampling time on salivary oestriol concentrations in pregnant women
145. Salivary estriol concentrations during normal pregnancies, and a comparison with plasma estriol
146. Radioimmunoassay of unconjugated estriol in saliva
147. Plasma and salivary estriol during pregnancy: preliminary observations
148. Estriol in saliva as an index of fetoplacental function
149. Variability in unconjugated and total estriol in serum during normal third-trimester pregnancy
150. Serum unconjugated estriol levels in the third trimester and their relationship to gestational age
151. Serum unconjugated estriol levels in the third trimester and their relationship to gestational age
152. Estimation of gestational age and maternal serum steroid concentrations. Total estriol
153. Plasma estriol in the evaluation of third-trimester gestational age
154. Plasma unconjugated oestriol in late pregnancy: circadian variation and the effect of meals and a glucose load
155. Circadian rhythms in maternal plasma cortisol and estriol concentrations at 30 to 31 and 38 to 39 weeks gestational age
156. variations in unconjugated and total plasma estriol levels in late normal pregnancy
157. Effects of serum lipids on radioimmunoassay of unconjugated estriol in serum
158. Saliva level of ethynylestradiol in presence of ethynodiol diacetate after oral administration
159. Radioimmunoassay of progesterone in saliva: application to the assessment of ovarian function
160. The role of salivary progesterone in studies of infertile women
161. Radioimmunoassay for progesterone in human saliva during the menstrual cycle
162. Saliva progesterone throughout the menstrual cycle and late pregnancy
163. Salivary progesterone as an index of the luteal function
164. Indices of ovulation: comparison of plasma and salivary levels of progesterone with urinary pregnanediol
165. Salivary progesterone throughout the menstrual cycle and pregnancy
166. The use of salivary progesterone assays to monitor menstrual cycles in Bangladeshi women
167. Salivary progesterone for investigating ovarian activity
168. Radioimmunoassay of plasma and salivary progesterone during the menstrual cycle
169. Radioimmunoassay of progesterone in saliva
170. Variation of salivary progesterone throughout the menstrual cycle
171. Salivary progesterone as an index of luteal function
172. A comparative study of clomiphene and epimestrol on plasma progesterone, CBG, TBG and SHBG, and salivary progesterone levels
173. Simultaneous plasma and saliva steroid measurements as an index of control in congenital adrenal hyperplasia (CAH). A longitudinal study
174. Free norethisterone as reflected by saliva concentrations of norethisterone during oral contraceptive use
175. A sensitive solid phase enzyme immunoassay for norethisterone (norethindrone) in saliva and plasma
176. Serum 17alpha-hydroxyprogesterone, progesterone, estradiol and testosterone in the diagnosis and management of congenital adrenal hyperplasia
177. Assay of hydroxyprogesterone in saliva (letter)
178. Enzyme immunoassay of 17-hydroxyprogesterone in plasma, microfilter paper blood and saliva of newbons, children and patients with congenital adrenal hyperplasia
179. Salivary and plasma androstenedione and 17-hydroxyprogesterone levels in congenital adrenal hyperplasia
180. Clinical application of salivary 17alpha-hydroxyprogesterone determinations
181. Salivary 17 alpha-hydroxyprogesterone in congenital adrenal hyperplasia
182. Control in congenital adrenal hyperplasia monitored by frequent saliva 17OH-progesterone measurements
183. 17alpha-hydroxyprogesterone, androstenedione and testosterone in normal children and in prepubertal patients with congenital adrenal hyperplasia
184. Circadian variation in plasma 17alpha-hydroxyprogesterone in patients with congenital adrenal hyperplasia
185. Circadian patterns of plasma cortisol, 17++-hydroxyprogesterone and testosterone in congenital adrenal hyperplasia
186. Plasma progesterone and 17++-hydroxyprogesterone in normal men and children with congenital adrenal hyperplasia
187. Menarche and subsequent ovarian function in girls with congenital adrenal hyperplasia
188. The measurement of 25-OHD in saliva
189. Development of an assay for the measurement of 25-hydroxyvitamin D in saliva and its use to study diurnal variations of 25-hydroxyvitamin D in man
190. Studies on the presence of 25 hydroxyvitamin D in human saliva
191. Transport of vitamin D: significance of free and total concentrations of the vitamin D metabolites
192. Peptides in saliva
193. Blood-group activity of human chorionic gonadotropin
194. General discussion
195. Turner's syndrome and carbohydrate metabolism. II. Parotid salivary insulin concentration in normal subjects and in patients with gonadal dysgenesis
196. The presence of immunologically reactive insulin in parotid saliva and its relation to changes in serum insulin concentration
197. Effect of ligation of the parotid duct on the carbohydrate tolerance of normal dogs
198. The influence of the parotid extract on the blood sugar and structure of the pancreas of the rat
199. Salivary gland hyperglycemic factor: an extrapancreatic source of glucagon-like material
200. Salivary gland glucagon in man and animals
201. The submaxillary gland as a possible source of glucagon
202. The identification of urogastrone in serum, saliva and gastric juice
203. Hypersecretion of submandibular saliva in male mice: trophic response in small intestine
204. Human epidermal growth factor (urogastrone) in human fluids detected by radioreceptor assay
205. Radioimmunoassay of human epidermal growth factor (urogastrone)
206. Studies on the gastric inhibitory substance in human saliva (salivogastrone). I. Experimental studies
207. Studies on the inhibitory substances of gastric secretion. II. Extraction and separation of sialogastrone from human saliva
208. Studies on the gastric secretion inhibitory substance in human saliva (salivogastrone). II. Clinical study
209. Effect of salivary glands on wound contraction in mice
210. The effect of epidermal growth factor on wound healing in mice
211. Epidermal growth factor and nerve factor in mouse saliva: a comparative study
212. Concentrations of epidermal growth factor, nerve growth factor, and submandibular gland renin in male and female mouse tissue and fluids
213. The mouse submandibular gland: an exocrine organ for growth factors
214. Sensitive method for the bioassay of melanocyte stimulating hormone in human saliva
215. Identification of transcalciferin as a major component of human parotid saliva
216. Thyroid stimulating substances in human saliva
217. Letter: gastrin-like immunoreactivity in salivary gland and saliva
218. A direct radioimmunoassay for tonin
219. Studies on the high molecular weight parotin-like substance in human saliva. II. Biological activity
220. Elimination of TRH in man
221. Immunoreactive thyroglobulin-like material derived from saliva
222. Carcinoembryonic antigen in normal human saliva
223. Cancer- and organ-specificity of the carcinoembryonic antigen
224. Carcinoembryonic antigen content of human nontumorous tissues and biological fluids
225. Bromocriptine concentration in saliva and plasma after long-term treatment of patients with Parkinson's Disease
226. Clinical importance of melatonin
227. Quantitative determination of prostaglandins in human gastric juice by radioimmunoassay
228. The disposition and metabolism of the synthetic prostaglandin fluprostenol (ICI 81,008) in the horse
229. Relationships between circulating and intra cellular thyroid hormones: Physiological implications
230. Salivary thyroxine as an estimate of free thyroxine: concise communication